Clinical Trial Update: Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study [Phase 3]

View source ↗

Summary

A Phase 3b trial is evaluating concurrent administration of mirikizumab with tirzepatide in adults with moderately to severely active ulcerative colitis and obe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Ulcerative Colitis

Drugs mentioned

• Mirikizumab (mirikizumab)
• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Ulcerative Colitis, Obesity or Overweight | Phase 3 | Status: RECRUITING